MEDI.F Stock Overview
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 6/6 |
Dividends | 0/6 |
MediPharm Labs Corp. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.058 |
52 Week High | CA$0.077 |
52 Week Low | CA$0.04 |
Beta | 0.97 |
1 Month Change | 15.80% |
3 Month Change | 13.08% |
1 Year Change | -14.35% |
3 Year Change | -84.64% |
5 Year Change | -98.61% |
Change since IPO | -96.60% |
Recent News & Updates
Recent updates
Shareholder Returns
MEDI.F | US Pharmaceuticals | US Market | |
---|---|---|---|
7D | -7.8% | -2.2% | -3.7% |
1Y | -14.3% | 11.6% | 20.5% |
Return vs Industry: MEDI.F underperformed the US Pharmaceuticals industry which returned 11.7% over the past year.
Return vs Market: MEDI.F underperformed the US Market which returned 20.2% over the past year.
Price Volatility
MEDI.F volatility | |
---|---|
MEDI.F Average Weekly Movement | 9.3% |
Pharmaceuticals Industry Average Movement | 9.6% |
Market Average Movement | 6.0% |
10% most volatile stocks in US Market | 16.4% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MEDI.F has not had significant price volatility in the past 3 months.
Volatility Over Time: MEDI.F's weekly volatility (9%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2015 | 166 | David Pidduck | www.medipharmlabs.com |
MediPharm Labs Corp., a pharmaceutical company, produces and sells pharmaceutical-quality cannabis oil and concentrates, and advanced derivative products in Canada and internationally. The company formulates, processes, packages, and distributes cannabis extracts and advanced cannabinoid-based products. It also provides GMP flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll products.
MediPharm Labs Corp. Fundamentals Summary
MEDI.F fundamental statistics | |
---|---|
Market cap | US$23.41m |
Earnings (TTM) | -US$9.48m |
Revenue (TTM) | US$23.95m |
1.0x
P/S Ratio-2.5x
P/E RatioIs MEDI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEDI.F income statement (TTM) | |
---|---|
Revenue | CA$33.06m |
Cost of Revenue | CA$24.96m |
Gross Profit | CA$8.10m |
Other Expenses | CA$21.18m |
Earnings | -CA$13.08m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.032 |
Gross Margin | 24.50% |
Net Profit Margin | -39.57% |
Debt/Equity Ratio | 4.0% |
How did MEDI.F perform over the long term?
See historical performance and comparison